Vedbæk, Denmark

Frederick Christian Grønvald

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederick Christian Grønvald. Retrieved from https://idiyas.com/inventor/frederick-christian-grandoslashnvald

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Frederick Christian Grønvald

Introduction: Frederick Christian Grønvald is a distinguished inventor based in Vedbæk, Denmark. With a pivotal patent to his name, he has made significant contributions to the field of biology, particularly in the regulation of meiosis. His work underscores the intersection of innovation and scientific research.

Latest Patents: Grønvald holds a notable patent for "Meiosis Regulating Compounds." This patent showcases certain novel sterol derivatives that can be utilized for regulating meiosis in oocytes as well as in male germ cells. This breakthrough has the potential to advance reproductive biology and associated fields.

Career Highlights: Throughout his career, Frederick Christian Grønvald has dedicated himself to research and innovation. His intellectual contributions have been instrumental in enhancing our understanding of biological processes, particularly in meiosis.

Collaborations: Grønvald has worked alongside esteemed colleagues such as Peter Faarup and Thorsten Blume. Their collaborative efforts signify a strong synergy in advancing scientific knowledge and developing innovative solutions in their field.

Conclusion: Frederick Christian Grønvald exemplifies the spirit of innovation through his patent and collaborative endeavors. His work not only contributes to scientific understanding but also holds promise for future advancements in biology and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…